Drug Discovery & Development
Incyte is a Wilmington, Delaware-based drug discovery and development company with a growing pipeline of novel small molecule drugs.
Product Pipeline - Learn more about our drug discovery programs.
Incyte's Clinical Trials
To learn more about Incyte's ongoing clinical trials, please go to the following links:
INCB18424: Myelofibrosis http://www.clinicaltrials.gov/ct2/show/NCT00509899
INCB18424: Polycythemia vera/Essential Thrombocytopenia http://www.clinicaltrials.gov/ct2/show/NCT00726232
INCB18424: Multiple myeloma http://www.clinicaltrials.gov/ct2/show/NCT00639002
INCB18424: Topical psoriasis http:://www.clinicaltrials.gov/ct2/show/NCT00617994
INCB13739: Type2 Diabetes(11BETA-HSD1)http://www.clinicaltrials.gov/ct2/show/NCT00698230
INCB19602: Type2 Diabetes(HM74a)http://www.clinicaltrials.gov/ct2/show/NCT00698789
